256 related articles for article (PubMed ID: 18987185)
41. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice.
Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H
J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570
[TBL] [Abstract][Full Text] [Related]
42. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.
Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB
Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404
[TBL] [Abstract][Full Text] [Related]
43. Contribution of reactive oxygen species to cerebral amyloid angiopathy, vasomotor dysfunction, and microhemorrhage in aged Tg2576 mice.
Han BH; Zhou ML; Johnson AW; Singh I; Liao F; Vellimana AK; Nelson JW; Milner E; Cirrito JR; Basak J; Yoo M; Dietrich HH; Holtzman DM; Zipfel GJ
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):E881-90. PubMed ID: 25675483
[TBL] [Abstract][Full Text] [Related]
44. Role of Suppressor of Cytokine Signaling 3 (SOCS3) in Altering Activated Microglia Phenotype in APPswe/PS1dE9 Mice.
Iwahara N; Hisahara S; Kawamata J; Matsumura A; Yokokawa K; Saito T; Fujikura M; Manabe T; Suzuki H; Matsushita T; Suzuki S; Shimohama S
J Alzheimers Dis; 2017; 55(3):1235-1247. PubMed ID: 27814300
[TBL] [Abstract][Full Text] [Related]
45. Edaravone Attenuates the Proinflammatory Response in Amyloid-β-Treated Microglia by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion.
Wang HM; Zhang T; Huang JK; Xiang JY; Chen JJ; Fu JL; Zhao YW
Cell Physiol Biochem; 2017; 43(3):1113-1125. PubMed ID: 28977782
[TBL] [Abstract][Full Text] [Related]
46. Glycoprotein NMB: a novel Alzheimer's disease associated marker expressed in a subset of activated microglia.
Hüttenrauch M; Ogorek I; Klafki H; Otto M; Stadelmann C; Weggen S; Wiltfang J; Wirths O
Acta Neuropathol Commun; 2018 Oct; 6(1):108. PubMed ID: 30340518
[TBL] [Abstract][Full Text] [Related]
47. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species.
Qin L; Liu Y; Cooper C; Liu B; Wilson B; Hong JS
J Neurochem; 2002 Nov; 83(4):973-83. PubMed ID: 12421370
[TBL] [Abstract][Full Text] [Related]
48. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
49. Cu(II) enhances the effect of Alzheimer's amyloid-β peptide on microglial activation.
Yu F; Gong P; Hu Z; Qiu Y; Cui Y; Gao X; Chen H; Li J
J Neuroinflammation; 2015 Jun; 12():122. PubMed ID: 26104799
[TBL] [Abstract][Full Text] [Related]
50. The KATP channel activator diazoxide ameliorates amyloid-β and tau pathologies and improves memory in the 3xTgAD mouse model of Alzheimer's disease.
Liu D; Pitta M; Lee JH; Ray B; Lahiri DK; Furukawa K; Mughal M; Jiang H; Villarreal J; Cutler RG; Greig NH; Mattson MP
J Alzheimers Dis; 2010; 22(2):443-57. PubMed ID: 20847430
[TBL] [Abstract][Full Text] [Related]
51. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
Bamberger ME; Harris ME; McDonald DR; Husemann J; Landreth GE
J Neurosci; 2003 Apr; 23(7):2665-74. PubMed ID: 12684452
[TBL] [Abstract][Full Text] [Related]
52. NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.
Park L; Anrather J; Zhou P; Frys K; Pitstick R; Younkin S; Carlson GA; Iadecola C
J Neurosci; 2005 Feb; 25(7):1769-77. PubMed ID: 15716413
[TBL] [Abstract][Full Text] [Related]
53. Microglia demonstrate age-dependent interaction with amyloid-β fibrils.
Floden AM; Combs CK
J Alzheimers Dis; 2011; 25(2):279-93. PubMed ID: 21403390
[TBL] [Abstract][Full Text] [Related]
54. NADPH oxidase and reactive oxygen species contribute to alcohol-induced microglial activation and neurodegeneration.
Qin L; Crews FT
J Neuroinflammation; 2012 Jan; 9():5. PubMed ID: 22240163
[TBL] [Abstract][Full Text] [Related]
55. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Chu J; Lauretti E; Craige CP; Praticò D
J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099
[TBL] [Abstract][Full Text] [Related]
56. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced.
Johnstone M; Gearing AJ; Miller KM
J Neuroimmunol; 1999 Jan; 93(1-2):182-93. PubMed ID: 10378882
[TBL] [Abstract][Full Text] [Related]
57. Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity.
Zhang D; Hu X; Qian L; Chen SH; Zhou H; Wilson B; Miller DS; Hong JS
J Neuroinflammation; 2011 Jan; 8(1):3. PubMed ID: 21232086
[TBL] [Abstract][Full Text] [Related]
58. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation.
Wu HY; Hudry E; Hashimoto T; Kuchibhotla K; Rozkalne A; Fan Z; Spires-Jones T; Xie H; Arbel-Ornath M; Grosskreutz CL; Bacskai BJ; Hyman BT
J Neurosci; 2010 Feb; 30(7):2636-49. PubMed ID: 20164348
[TBL] [Abstract][Full Text] [Related]
59. Microglia prevent beta-amyloid plaque formation in the early stage of an Alzheimer's disease mouse model with suppression of glymphatic clearance.
Feng W; Zhang Y; Wang Z; Xu H; Wu T; Marshall C; Gao J; Xiao M
Alzheimers Res Ther; 2020 Oct; 12(1):125. PubMed ID: 33008458
[TBL] [Abstract][Full Text] [Related]
60. CLIC1 null mice demonstrate a role for CLIC1 in macrophage superoxide production and tissue injury.
Ulmasov B; Bruno J; Oshima K; Cheng YW; Holly SP; Parise LV; Egan TM; Edwards JC
Physiol Rep; 2017 Mar; 5(5):. PubMed ID: 28275112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
